First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer

被引:17
作者
Wegen, Simone [1 ]
Roth, Katrin Sabine [2 ,3 ]
Weindler, Jasmin [2 ,3 ]
Claus, Karina [1 ]
Linde, Philipp [1 ]
Trommer, Maike [1 ]
Akuamoa-Boateng, Dennis [1 ]
van Heek, Lutz [2 ,3 ]
Baues, Christian [1 ]
Schoemig-Markiefka, Birgid [4 ]
Schomaecker, Klaus [2 ,3 ]
Fischer, Thomas [2 ,3 ]
Drzezga, Alexander [2 ,3 ,5 ,6 ]
Kobe, Carsten [2 ,3 ]
Koehler, Christhardt [7 ]
Marnitz, Simone [1 ]
机构
[1] Univ Hosp Cologne, Dept Radiat Oncol Cyberknife & Radiotherapy, Kerpener Str 62, D-50937 Cologne, Germany
[2] Univ Cologne, Fac Med, Dept Nucl Med, Cologne, Germany
[3] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[4] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[5] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany
[6] Forschungszentrum Julich, Inst Neurosci & Med INM 2, Mol Org Brain, Julich, Germany
[7] Asklepios Hosp Grp, Dept Special Operat & Oncol Gynecol, Asklepios Clin Hamburg Altona, Hamburg, Germany
关键词
FAPI PET; cervical cancer; FDG PET; surgical lymph node staging; CHEMORADIATION; METASTASES;
D O I
10.1097/RLU.0000000000004505
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
IntroductionIn several solid tumors, fibroblast activation protein (FAP) is overexpressed by cancer-associated fibroblasts in the tumor microenvironment. Preliminary evidence suggests that detection and staging are feasible with PET/CT imaging using [Ga-68]-radiolabeled inhibitors of FAP also in cervical cancer (CC). Our study aims to explore the accuracy of [Ga-68]Ga-fibroblast activation protein inhibitor (FAPI)-46 PET/CT and [F-18]F-FDG PET/CT compared with histopathological results of surgical lymph node (LN) staging before primary chemoradiation.MethodsSeven consecutive women with treatment-naive and biopsy-proven locally advanced CC underwent both whole-body [Ga-68]Ga-FAPI-46- and [F-18]F-FDG PET/CT, for imaging nodal staging before systematic laparoscopic lymphadenectomy of the pelvic and para-aortic region. Location and number of suspicious LNs in PET imaging were recorded and compared with the results of histopathological analysis, including immunohistochemical staining for FAP.ResultsAll 7 patients had focal uptake above background in their tumor lesions in [Ga-68]Ga-FAPI-46 PET/CT. [Ga-68]Ga-FAPI-46 PET/CT showed a higher tumor-to-background ratio (TBR) in primary tumor as well as in LN metastasis. Median TBRmax values using liver were 32.02 and 5.15 for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Median TBRmax using blood pool was 18.45 versus 6.85 for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Higher TBR also applies for nodal metastasis: TBRmax was 14.55 versus 1.39 (liver) and 7.97 versus 1.8 (blood pool) for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Overall, [Ga-68]Ga-FAPI-46 PET/CT detected more lesions compared with [F-18]F-FDG PET/CT. Following surgical staging, a total of 5 metastatic LNs could be pathologically confirmed, of which 2 and 4 were positive by [F-18]F-FDG PET/CT and [Ga-68]Ga-FAPI-46 PET/CT, respectively.Conclusion[Ga-68]Ga-FAPI-46 PET/CT seems useful to improve detection of nodal metastasis in patients with CCs. Future studies should aim to compare [Ga-68]Ga-FAPI-46 PET/CT to surgical staging of pelvic and para-aortic LNs in patients with locally advanced CC.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 50 条
  • [31] Value of [18F]AlF-NOTA-FAPI-04 PET/CT for differential diagnosis of malignant and various inflammatory lung lesions: comparison with [18F]FDG PET/CT
    Qiao, Kailin
    Qin, Xueting
    Fu, Shuai
    Ren, Jiazhong
    Jia, Jing
    Hu, Xinying
    Tao, Yuanyuan
    Yuan, Shuanghu
    Wei, Yuchun
    EUROPEAN RADIOLOGY, 2024, 34 (03) : 1948 - 1959
  • [32] The Value of 68Ga-PSMA PET/CT Following Equivocal 18F-NaF PET/CT in Prostate Cancer Patients
    Madsen, Claus
    Ostergren, Peter
    Haarmark, Christian
    DIAGNOSTICS, 2020, 10 (06)
  • [33] 18F-FDG PET/CT in locally advanced cervical cancer: A review
    Caresia-Aroztegui, A. P.
    Delgado-Bolton, R. C.
    Alvarez-Ruiz, S.
    Del Puig Cozar-Santiago, M.
    Orcajo-Rincon, J.
    de Arcocha-Torres, M.
    Garcia-Velloso, M. J.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (01): : 59 - 68
  • [34] High-grade endometrial cancer: value of [18F]FDG PET/CT in preoperative staging
    Picchio, Maria
    Mangili, Giorgia
    Gajate, Ana M. Samanes
    De Marzi, Patrizia
    Spinapolice, Elena G.
    Mapelli, Paola
    Giovacchini, Giampiero
    Sigismondi, Cristina
    Vigano, Riccardo
    Sironi, Sandro
    Messa, Cristina
    NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (06) : 506 - 512
  • [35] Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer
    Wu, Junhao
    Deng, Hao
    Zhong, Haoshu
    Wang, Tao
    Rao, Zijuan
    Wang, Yingwei
    Chen, Yue
    Zhang, Chunyin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review
    Chowdhury, Fahmid U.
    Shah, Nehal
    Scarsbrook, Andrew F.
    Bradley, Kevin M.
    POSTGRADUATE MEDICAL JOURNAL, 2010, 86 (1013) : 174 - 182
  • [37] [18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
    Miao, Zhi
    Zhao, Xiaomeng
    Li, Xuanwen
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [38] Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors
    Panagiotidis, Emmanouil
    Alshammari, Alshaima
    Miehopoulou, Sofia
    Skoura, Evangelia
    Naik, Keval
    Maragkoudakis, Emmanouil
    Mohmaduvesh, Mullan
    Al-Harbi, Mohammed
    Belda, Maria
    Caplin, Martyn E.
    Toumpanakis, Christos
    Bomanji, Jamshed
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (01) : 91 - 96
  • [39] Multicenter Comparison of 18F-FDG and 68Ga-DOTA-Peptide PET/CT for Pulmonary Carcinoid
    Lococo, Filippo
    Perotti, Germano
    Cardillo, Giuseppe
    De Waure, Chiara
    Filice, Angelina
    Graziano, Paolo
    Rossi, Giulio
    Sgarbi, Giorgio
    Stefanelli, Antonella
    Giordano, Alessandro
    Granone, Pierluigi
    Rindi, Guido
    Versari, Annibale
    Rufini, Vittoria
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (03) : E183 - E189
  • [40] Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer
    Sawicki, Lino M.
    Grueneisen, Johannes
    Schaarschmidt, Benedikt M.
    Buchbender, Christian
    Nagarajah, James
    Umutlu, Lale
    Antoch, Gerald
    Kinner, Sonja
    EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (02) : 459 - 465